Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Achievement and CYP2C9[original query] |
---|
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Arthritis and rheumatism 2004 Jul 50 (7): 2202-10. Takada Kazuki, Arefayene Million, Desta Zeruesenay, Yarboro Cheryl H, Boumpas Dimitrios T, Balow James E, Flockhart David A, Illei Gabor |
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Blood 2011 Sep 118 (11): 3163-71. Gong Inna Y, Tirona Rommel G, Schwarz Ute I, Crown Natalie, Dresser George K, Larue Samantha, Langlois Nicole, Lazo-Langner Alejandro, Zou Guangyong, Roden Dan M, Stein C Michael, Rodger Marc, Carrier Marc, Forgie Melissa, Wells Philip S, Kim Richard |
Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial. Trials 2012 Dec 13 (1): 1. Carcas AJ, Borobia AM, Velasco M, Abad-Santos F, Díaz MQ, Fernández-Capitán C, Ruiz-Giménez N, Madridano O, Sillero PL |
The impact of the CYP2C9 and VKORC1 polymorphisms on acenocoumarol dose requirements in a Romanian population. Blood cells, molecules & diseases 2012 Nov . Buzoianu AD, Militaru FC, Vesa SC, Trifa AP, Cri?an S |
Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese. European journal of clinical pharmacology 2016 Nov 72 (11): 1327-1334. Zeng Wu-Tao, Xu Qing, Li Cheng-Hsun, Chen Wei-Yan, Sun Xiu-Ting, Wang Xiang, Yang Yi-Ying, Shi Hui, Yang Zhi-She |
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of medical science : AMS 2018 Oct 14 (6): 1416-1423. Belohlavkova Petra, Vrbacky Filip, Voglova Jaroslava, Racil Zdenek, Zackova Daniela, Hrochova Katerina, Malakova Jana, Mayer Jiri, Zak Pav |
Genetic contribution to lipid target achievement with statin therapy: a prospective study. The pharmacogenomics journal 2019 Dec . Ruiz-Iruela Cristina, Candás-Estébanez Beatriz, Pintó-Sala Xavier, Baena-Díez Neus, Caixàs-Pedragós Assumpta, Güell-Miró Roser, Navarro-Badal Rosa, Calmarza Pilar, Puzo-Foncilla Jose Luis, Alía-Ramos Pedro, Padró-Miquel Ariad |
- Page last reviewed:Feb 1, 2024
- Content source: